Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Track NEOG with free AI briefings, catalyst countdowns, and dilution alerts.

NEOG · NEOGEN CORP

Company guidance, FDA catalysts, dilution risk and cash runway, built from SEC, FDA and ClinicalTrials.gov filings and updated every day.

$172M Cash on Hand
CF+ Cash Runway
Follow NEOG by email Get an email when NEOG reports key news in an SEC filing, pushes back a promised milestone, files for a stock offering, lands on the Downside Radar or has an FDA decision. Free, no account needed.

We send one confirmation email first. Only emails about NEOG, unsubscribe in one click. Privacy

📣 What NEOG Says Is Next

Quoted word for word from the company's press releases filed with the SEC. Timing is the company's own guidance, not a BioRadar estimate.

📄 Latest SEC Filings in Plain English

Each summary is written by AI from the filing itself, and one that names a number or a name the filing does not contain is not shown. Quarterly and annual reports are listed by period. Read the filing before acting on it.

💰 Cash Runway & Dilution Risk

NEOG holds $172M in cash and short-term investments (as of Aug 31, 2026) and its operations are currently cash-flow neutral or positive.

Dilution pressure: 0 · Low

Source: SEC EDGAR (XBRL cash flow and financing filings). Dilution Watch: every company ranked → · Get an alert when NEOG files for a raise →

👥 Who Owns NEOG

Insiders 0.3% Institutions (426 holders) 99.7% Public and other holders 0%
HolderTypeShares% of sharesAs of
Neuberger Berman Group LLC Institution (13G, 5%+) 16,570,795 7.59% 2026-06-30
Vanguard Portfolio Management Institution (13G, 5%+) 12,916,330 5.92% 2026-03-31
Vanguard Capital Management Institution (13G, 5%+) 11,164,628 5.11% 2026-03-31
James C Borel
Director · +20,558 options
Insider 106,737 0.05% 2026-10-29
David H. Naemura
Former CFO
Insider 90,388 0.04% 2025-12-01
Amy M Rocklin
Former Chief Legal Officer
Insider 82,182 0.04% 2026-05-18
Richard Bryan Riggsbee
CFO · +261,702 options
Insider 51,502 0.02% 2026-08-14
James P Tobin
Director
Insider 43,347 0.02% 2025-10-27
Jeffrey D Capello
Director · +20,558 options
Insider 42,892 0.02% 2026-10-29
Jennifer Evans Stacey
Chief Legal Officer · +285,796 options
Insider 38,627 0.02% 2026-08-14
Aashima Gupta
Director · +20,558 options
Insider 38,180 0.02% 2026-10-29
Gregory S Hastings
VP, Animal Health
Insider 33,449 0.02% 2026-10-29

Share count 218,306,034 (latest 10-Q/10-K). Insiders: each officer's, director's and 10% owner's latest Form 3, 4 or 5, direct and indirect shares; options are not counted. 5%+ holders: latest Schedule 13D or 13G of each holder above 5%. Institutions: the total held by all 13F filers (Yahoo Finance); the table lists the largest. Sources have different dates, so the split is approximate. Source: SEC EDGAR.

Get the full NEOG picture

The 7-day free trial adds AI daily briefings, sentiment tracking, trial enrollment progress and email alerts for NEOG and every other ticker you follow. Card required, cancel anytime.

Start 7-day free trial →

Data: SEC EDGAR, FDA, ClinicalTrials.gov, Yahoo Finance • Informational purposes only, not investment advice. • All tracked stocks A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.